Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Genzyme Beats Estimates, CEO Reports Excellent' Third Quarter

Oct. 19, 2005

By Jennifer Boggs

Genzyme Beats Estimates, CEO Reports Excellent' Third Quarter

Oct. 19, 2005

By Jennifer Boggs

Tercica Accessing $75M Via Equity-Based Line Of Credit

Oct. 18, 2005

By Jennifer Boggs

Tercica Accessing $75M Via Equity-Based Line Of Credit

Oct. 18, 2005

By Jennifer Boggs

Tigris Series A Gets $11.6M For Topical Product In HPV

Oct. 17, 2005

By Jennifer Boggs

Tigris Series A Gets $11.6M For Topical Product In HPV

Oct. 17, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...